Position in MRNA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$62,241,193
+$16,276,185 QoQ
Shares Held
888,779
-1.8% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#39
of 772 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names. MRNA ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
This page
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in MRNA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,241,193 | 888,779 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $45,965,008 | 904,823 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $33,725,147 | 1,143,613 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,244,700 | 1,016,055 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,091,146 | 909,429 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $37,855,468 | 1,335,290 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $50,156,828 | 1,206,273 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $44,842,926 | 671,000 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $87,332,191 | 735,429 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $69,007,080 | 647,589 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $75,021,098 | 754,360 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $58,518,945 | 566,550 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $68,618,581 | 564,762 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $109,473,356 | 712,810 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $145,008,838 | 807,309 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $87,541,537 | 740,309 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $41,800,188 | 292,616 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $38,634,811 | 224,282 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $135,306,569 | 532,745 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $183,777,189 | 477,517 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $104,458,003 | 444,540 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||